Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scimplify
Bengaluru, Karnataka, Indiascimplify.com ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Other
01
Overview
Scimplify does not develop its own clinical assets but provides end-to-end R&D, custom synthesis, process development, manufacturing scale-up, regulatory support and supply chain solutions to pharma/life science companies. It enables rapid development of APIs/intermediates with high quality standards. No direct clinical results since it’s not an innovator biotech/pharma.
- Modalities
- Small molecule (APIs and intermediates)Peptides (as per expertise in nucleosides and peptides)Custom synthesis/chemical intermediates
- Industry
- Contract Manufacturing Organization
02
Partnerships
Partners with >150 chemical manufacturers globally through its Atoms platform; no specific major pharma/biotech partnerships named publicly.
Beyond the preview
Go deeper on Scimplify.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scimplify.